IRIS UniCatt

Cauda, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.820
NA - Nord America 12.372
AS - Asia 5.694
SA - Sud America 1.007
AF - Africa 88
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 24
Totale 33.032
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.184
DE - Germania 4.512
CN - Cina 2.586
SE - Svezia 2.144
SG - Singapore 1.822
IT - Italia 1.597
PL - Polonia 1.150
UA - Ucraina 1.132
FR - Francia 1.074
BR - Brasile 910
IE - Irlanda 601
GB - Regno Unito 541
ID - Indonesia 365
FI - Finlandia 344
RU - Federazione Russa 277
IN - India 271
TR - Turchia 270
CA - Canada 105
BE - Belgio 88
AT - Austria 81
NL - Olanda 78
HK - Hong Kong 68
IR - Iran 52
MX - Messico 49
JP - Giappone 45
VN - Vietnam 44
KR - Corea 35
AR - Argentina 31
CH - Svizzera 26
ES - Italia 25
CI - Costa d'Avorio 23
EU - Europa 22
MA - Marocco 22
AU - Australia 21
CZ - Repubblica Ceca 19
BD - Bangladesh 18
BG - Bulgaria 18
EC - Ecuador 18
CO - Colombia 16
GR - Grecia 15
LT - Lituania 15
ZA - Sudafrica 14
BZ - Belize 13
UZ - Uzbekistan 12
CL - Cile 11
IQ - Iraq 11
PT - Portogallo 10
RO - Romania 10
AL - Albania 9
PH - Filippine 9
PK - Pakistan 9
EE - Estonia 8
EG - Egitto 8
HU - Ungheria 8
KZ - Kazakistan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
MY - Malesia 7
PA - Panama 7
AZ - Azerbaigian 6
JO - Giordania 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
DK - Danimarca 5
LA - Repubblica Popolare Democratica del Laos 5
TN - Tunisia 5
TW - Taiwan 5
VA - Santa Sede (Città del Vaticano) 5
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
LV - Lettonia 4
NG - Nigeria 4
NO - Norvegia 4
NP - Nepal 4
PE - Perù 4
UY - Uruguay 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
HR - Croazia 3
LU - Lussemburgo 3
MO - Macao, regione amministrativa speciale della Cina 3
PY - Paraguay 3
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
IM - Isola di Man 2
KW - Kuwait 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GL - Groenlandia 1
Totale 33.016
Salva come PNG Salva come JPEG
Città #
Chandler 2.407
Singapore 1.001
Ashburn 954
Jacksonville 752
Hangzhou 632
Warsaw 595
Dublin 591
San Mateo 568
Kraków 542
Nanjing 434
New York 409
Ann Arbor 394
Jakarta 361
Dearborn 353
Wilmington 343
Houston 310
Woodbridge 309
Nürnberg 294
Milan 255
Izmir 229
Boston 224
Lawrence 185
Redmond 185
Moscow 183
Fairfield 182
Cattolica 181
Beijing 180
Rome 180
Nanchang 173
Seattle 173
Marseille 152
Princeton 151
Redwood City 136
Lancaster 123
Los Angeles 119
Munich 115
Bremen 110
Shenyang 102
Boardman 101
The Dalles 94
Kunming 89
Brussels 82
Helsinki 79
Mountain View 75
Hebei 73
Norwalk 71
Frankfurt am Main 70
Hefei 65
Chicago 64
São Paulo 63
University Park 63
Cambridge 62
Hong Kong 62
Tianjin 61
Fremont 59
Changsha 57
London 56
Leawood 53
Vienna 51
Guangzhou 50
Jiaxing 50
Nuremberg 49
Zhengzhou 48
Düsseldorf 47
Augusta 45
Shanghai 44
Pune 43
Jinan 38
North Bergen 37
Toronto 37
San Jose 36
Verona 36
Washington 35
Ottawa 33
Seoul 33
Lauterbourg 32
Simi Valley 32
Rio de Janeiro 30
Amsterdam 29
Paris 26
Philadelphia 25
Abidjan 23
San Francisco 23
Buffalo 22
Kish 21
Portsmouth 21
Belo Horizonte 20
Falls Church 20
Andover 19
Edinburgh 19
Santa Clara 19
Mexico City 18
Phoenix 18
Tokyo 18
Bexley 17
Brooklyn 17
Casalecchio di Reno 17
Changchun 17
Lanzhou 17
Brasília 16
Totale 17.234
Salva come PNG Salva come JPEG
Nome #
New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years 359
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 336
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 331
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 316
Factors associated with mortality in bacteremic patients with hematologic malignancies. 314
Factors associated with mortality in bacteremic patients with haematologic malignancies 310
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 306
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 279
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 270
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 235
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 235
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 223
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 222
La pandemia di COVID-19: un limite o una frontiera per la Legge 24/2017? 213
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 196
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 192
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 189
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 188
Factors associated with mortality in bacteremic patients with hematologic malignancies. 179
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 179
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 179
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 177
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 177
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 172
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 172
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 167
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 163
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 163
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 162
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 152
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 151
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 151
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 149
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 148
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 146
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 146
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 145
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 145
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 145
Variability of raltegravir plasma levels in the clinical setting 141
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 141
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 137
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 137
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 136
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 136
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 136
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 135
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis 134
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 134
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 133
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 132
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 132
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 132
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 132
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 128
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 126
Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy 126
Initial antifungal strategy does not correlate with mortality in patients with candidemia 124
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 123
Attitudes and practices of dentists treating HIV patients in HAART era. 123
Testimonianze dalle periferie del mondo. Sei anni di Charity Work Program Quaderni del CeSI Edizione Vita e Pensiero . 123
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 123
A real-time integrated framework to support clinical decision making for covid-19 patients 123
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 122
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 121
Comparison of expression vectors in Lactobacillus reuteri strains 120
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 120
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 120
Psychopathological profile in COVID-19 patients including healthcare workers: the implications 119
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 119
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 119
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 119
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 119
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 118
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 118
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 118
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar year: a cohort study 117
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study 117
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 116
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 116
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 116
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 115
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 115
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 114
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 114
Cognitive reserve and neuropsychological functioning in older HIV-infected people 114
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 113
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 112
Effect of aging and human immunodeficiency virus infection on cognitive abilities 112
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 112
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 111
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 111
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study 111
Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections 111
Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1 110
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 110
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients, a systematic review and meta-analysis 110
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 110
Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction? 108
Totale 15.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020344 0 0 0 0 0 0 0 0 0 0 0 344
2020/20212.721 216 292 70 269 331 173 286 61 408 124 430 61
2021/20223.160 258 258 85 241 134 109 70 517 126 222 485 655
2022/20236.603 837 944 540 962 516 741 282 524 837 124 210 86
2023/20243.159 138 878 98 248 128 521 190 100 53 108 366 331
2024/20255.380 135 202 500 208 619 218 179 341 1.050 545 1.210 173
Totale 33.408